Page 2,901«..1020..2,9002,9012,9022,903..2,9102,920..»

China medical tourism–Brain Injury–stem cells therapy – Video

Posted: January 2, 2012 at 2:02 am

26-12-2011 21:20 Many of our patients travel to Guangzhou from all over the world for medical treatment and tourism. China medical tourism can help with becoming a patient, travel arrangements and language assistance

Read the original:
China medical tourism--Brain Injury--stem cells therapy - Video

Posted in Stem Cell Treatments | Comments Off on China medical tourism–Brain Injury–stem cells therapy – Video

Adult Stem Cell Research – Video

Posted: January 2, 2012 at 2:02 am

17-12-2011 15:24 http://www.StemCellTreatment.org Thanks to adult stem cell research, stem cell therapy is going mainstream.

Read more:
Adult Stem Cell Research - Video

Posted in Stem Cell Research | Comments Off on Adult Stem Cell Research – Video

Stem Cell Therapy News Channel 12 Health – Dr Damon Noto.flv – Video

Posted: January 1, 2012 at 11:55 pm

16-12-2011 14:38 Learn about adult stem cells and how they can help you in the areas of orthopedic and degenerative disease, sports injuries, pain in the knees, shoulders, elbows, and back or spinal injuries.

Read the rest here:
Stem Cell Therapy News Channel 12 Health - Dr Damon Noto.flv - Video

Posted in Stem Cell Therapy | Comments Off on Stem Cell Therapy News Channel 12 Health – Dr Damon Noto.flv – Video

China medical tourism–Ataxia Multiple System Atrophy–stem cell therapy – Video

Posted: January 1, 2012 at 6:40 pm

24-12-2011 23:08 Many of our patients travel to Guangzhou from all over the world for medical treatment and tourism. China medical tourism can help with becoming a patient, travel arrangements and language assistance. If you want to know more about our services, please browse the web:htttp://www.medicaltourism.hk/ or mail to us: giels-x@medicaltourism.hk firstcare-china@hotmail.com Joe Leone never thought he'd go to China.

Read more from the original source:
China medical tourism--Ataxia Multiple System Atrophy--stem cell therapy - Video

Posted in Cell Therapy | Comments Off on China medical tourism–Ataxia Multiple System Atrophy–stem cell therapy – Video

Are Too Many Older People Screened for Cancer?

Posted: January 1, 2012 at 4:53 pm

(HealthDay News) -- Many older Americans get screened for colon, breast, prostate and cervical cancer even though guidelines recommend against routinely screening the elderly, a new study finds.

As the population of the United States continues to age, balancing good health care with costs will be a continuing battle, experts say. "In an era of escalating health care utilization and expenditures in the United States, identifying areas for cost containment while concurrently improving quality of care in our health care system is increasingly paramount," said lead researcher Keith Bellizzi, an assistant professor of human development and family studies at the University of Connecticut in Storrs.

"Perhaps this area of health care warrants further attention," Bellizzi added.

Currently, nearly 37 million people in the United States are 65 and older, and that number will probably double by 2030. Historically, older adults have been excluded from cancer clinical trials, so what is known about the effectiveness of screening in seniors is limited, he said.

The U.S. Preventive Services Task Force recommends against routine screening for breast, colorectal, and prostate cancer at age 75 and beyond, and advises against cervical cancer testing after 65, according to the study. Read more...

Ayurtox for Body Detoxification

Source:
http://feeds.feedburner.com/integratedmedicine

Posted in Integrative Medicine | Comments Off on Are Too Many Older People Screened for Cancer?

2011 EMA Committee for Advanced Therapies (CAT) classification record. What can be learned?

Posted: January 1, 2012 at 4:53 pm

Tweet 


What follows is the record of "classifications" done by the ATMP CAT in 2011 related to anything I would call "cell therapies". 


In my opinion there are a couple surprises. I'm surprised at the non-cardiac cells (MNCs, CD133s, and MSCs) for cardiac disease/repair being designated TEPs. I'm also surprised at the islets not being classified as an ATMP.


I've tapped into my European and/or regulatory colleagues to help explain those two as well as help us draw any other conclusions or observations we can make in terms of how the CAT is thinking based on the compendium of classifications we have to-date.  I'll post an update here when I have something useful.
______


In January, the following product was classified as a tissue engineered product - not combined:

  • Layer of autologous corneal epithelium containing stem cells intended for the treatment of extended corneal lesions



In April, the following product was classified as a tissue engineered product, combined: 

  • Allogeneic human fibroblasts cultured onto a biodegradable matrix, intended for use of conditions in the therapeutic area of dermatology



In May, the following product was classified as a somatic cell therapy medicinal product: 

  • Heterologous human adult liver-derived progenitor cells, intended for the treatment of inborn errors of liver metabolis



In July, the following product was classified as a Tissue Engineered Product, non-combined:

  • Suspension of allogeneic bone-marrow derived osteoblastic cells, intended for the treatment of non-union, delayed union or other fractures. 



In September, the following product was classified as a Tissue Engineered Product, non-combined:

  • Autologous mesenchymal stem cells (MSC), intended for the treatment of chronic heart failure symptoms by improvement in exercise capacity of NYHA class II and III chronic heart failure patients receiving standard therapy

     and the following product was not classified as an ATMP: 

  • Human islets of Langerhans, intended for: Post pancreatectomy for benign pancreatic pathologies (autologous); Treatment of severe forms of type 1 diabetes (Allogeneic)



In October, the following product was classified as a somatic cell therapy medicinal product: 

  • Autologous dendritic cell (DCs) immunotherapy consisting of autologous mature DCs coelectroporated with autologous RCC IVT RNA and synthetic CD40L IVT RNA, intended for the treatment of patients with advanced renal cell carcinoma



In November, the following products were classified as tissue-engineered products:

  • Concentrate of autologous bone marrow mononuclear cells (MNC), intended for improvement of heart function and quality of life in patients with chronic ischaemic heart disease and after MI.
  • CD 133+ Autologous bone marrow derived stem cells, intended for Improvement of heart function (LVEF) and quality of life in patients with chronic ischemic heart disease and after MI



In December, the following product was classified as somatic cell therapy medicinal product:

  • Autologous CD4+ T cells targeted to cells presenting class II restricted epitopes, intended forthe treatment of autoimmune diseases with MHC restricted specific immunity e.g. multiple sclerosis, type I diabetes or graft rejection.

Source:
http://feeds.feedburner.com/CellTherapyBlog

Posted in Regenerative Medicine | Comments Off on 2011 EMA Committee for Advanced Therapies (CAT) classification record. What can be learned?

The Top 10 Science Stories of 2011

Posted: January 1, 2012 at 4:53 pm

Inevitably, year-end lists invite plenty of debate and criticism, and Scientific American 's is no exception. Certainly, we could have included the discovery of new worlds beyond our solar system, including Kepler 22 b, an exoplanet in the "Goldilocks" zone of habitability, as well as the first known Earth-size exoplanets . Or noted the accumulating evidence suggesting that hydraulic fracturing, or fracking, to retrieve natural gas is likely to contaminate water supplies. (Final New York State regulations, expected in mid-2012, could determine the future of fracking in the U.S.)

[More]

Add to digg
Add to StumbleUpon
Add to Reddit
Add to Facebook
Add to del.icio.us
Email this Article


Source:
http://rss.sciam.com/sciam/topic/gene-therapy

Posted in Gene therapy | Comments Off on The Top 10 Science Stories of 2011

Are Too Many Older People Screened for Cancer?

Posted: January 1, 2012 at 4:52 pm

(HealthDay News) -- Many older Americans get screened for colon, breast, prostate and cervical cancer even though guidelines recommend against routinely screening the elderly, a new study finds.

As the population of the United States continues to age, balancing good health care with costs will be a continuing battle, experts say. "In an era of escalating health care utilization and expenditures in the United States, identifying areas for cost containment while concurrently improving quality of care in our health care system is increasingly paramount," said lead researcher Keith Bellizzi, an assistant professor of human development and family studies at the University of Connecticut in Storrs.

"Perhaps this area of health care warrants further attention," Bellizzi added.

Currently, nearly 37 million people in the United States are 65 and older, and that number will probably double by 2030. Historically, older adults have been excluded from cancer clinical trials, so what is known about the effectiveness of screening in seniors is limited, he said.

The U.S. Preventive Services Task Force recommends against routine screening for breast, colorectal, and prostate cancer at age 75 and beyond, and advises against cervical cancer testing after 65, according to the study. Read more...

Ayurtox for Body Detoxification

Source:
http://feeds.feedburner.com/integratedmedicine

Posted in Integrative Medicine | Comments Off on Are Too Many Older People Screened for Cancer?

2011 EMA Committee for Advanced Therapies (CAT) classification record. What can be learned?

Posted: January 1, 2012 at 4:52 pm

Tweet 


What follows is the record of "classifications" done by the ATMP CAT in 2011 related to anything I would call "cell therapies". 


In my opinion there are a couple surprises. I'm surprised at the non-cardiac cells (MNCs, CD133s, and MSCs) for cardiac disease/repair being designated TEPs. I'm also surprised at the islets not being classified as an ATMP.


I've tapped into my European and/or regulatory colleagues to help explain those two as well as help us draw any other conclusions or observations we can make in terms of how the CAT is thinking based on the compendium of classifications we have to-date.  I'll post an update here when I have something useful.
______


In January, the following product was classified as a tissue engineered product - not combined:

  • Layer of autologous corneal epithelium containing stem cells intended for the treatment of extended corneal lesions



In April, the following product was classified as a tissue engineered product, combined: 

  • Allogeneic human fibroblasts cultured onto a biodegradable matrix, intended for use of conditions in the therapeutic area of dermatology



In May, the following product was classified as a somatic cell therapy medicinal product: 

  • Heterologous human adult liver-derived progenitor cells, intended for the treatment of inborn errors of liver metabolis



In July, the following product was classified as a Tissue Engineered Product, non-combined:

  • Suspension of allogeneic bone-marrow derived osteoblastic cells, intended for the treatment of non-union, delayed union or other fractures. 



In September, the following product was classified as a Tissue Engineered Product, non-combined:

  • Autologous mesenchymal stem cells (MSC), intended for the treatment of chronic heart failure symptoms by improvement in exercise capacity of NYHA class II and III chronic heart failure patients receiving standard therapy

     and the following product was not classified as an ATMP: 

  • Human islets of Langerhans, intended for: Post pancreatectomy for benign pancreatic pathologies (autologous); Treatment of severe forms of type 1 diabetes (Allogeneic)



In October, the following product was classified as a somatic cell therapy medicinal product: 

  • Autologous dendritic cell (DCs) immunotherapy consisting of autologous mature DCs coelectroporated with autologous RCC IVT RNA and synthetic CD40L IVT RNA, intended for the treatment of patients with advanced renal cell carcinoma



In November, the following products were classified as tissue-engineered products:

  • Concentrate of autologous bone marrow mononuclear cells (MNC), intended for improvement of heart function and quality of life in patients with chronic ischaemic heart disease and after MI.
  • CD 133+ Autologous bone marrow derived stem cells, intended for Improvement of heart function (LVEF) and quality of life in patients with chronic ischemic heart disease and after MI



In December, the following product was classified as somatic cell therapy medicinal product:

  • Autologous CD4+ T cells targeted to cells presenting class II restricted epitopes, intended forthe treatment of autoimmune diseases with MHC restricted specific immunity e.g. multiple sclerosis, type I diabetes or graft rejection.

Source:
http://feeds.feedburner.com/CellTherapyBlog

Posted in Regenerative Medicine | Comments Off on 2011 EMA Committee for Advanced Therapies (CAT) classification record. What can be learned?

The Top 10 Science Stories of 2011

Posted: January 1, 2012 at 4:52 pm

Inevitably, year-end lists invite plenty of debate and criticism, and Scientific American 's is no exception. Certainly, we could have included the discovery of new worlds beyond our solar system, including Kepler 22 b, an exoplanet in the "Goldilocks" zone of habitability, as well as the first known Earth-size exoplanets . Or noted the accumulating evidence suggesting that hydraulic fracturing, or fracking, to retrieve natural gas is likely to contaminate water supplies. (Final New York State regulations, expected in mid-2012, could determine the future of fracking in the U.S.)

[More]

Add to digg
Add to StumbleUpon
Add to Reddit
Add to Facebook
Add to del.icio.us
Email this Article


Source:
http://rss.sciam.com/sciam/topic/gene-therapy

Posted in Gene therapy | Comments Off on The Top 10 Science Stories of 2011

Page 2,901«..1020..2,9002,9012,9022,903..2,9102,920..»